AZOPRES BR
BRINZOLAMIDE USP + BRIMONIDINE TARTRATE USP
| NAME | STRENGTH | PACK SIZE | DOSAGE FORM |
|---|---|---|---|
| AZOPRES BR 1% W/V + 0.2% W/V | 1% W/V + 0.2% W/V | 5 ML | EYE DROP |
Azopres Br Eye Suspension : Each ml contains Brinzolamide USP 10 mg and Brimonidine Tartrate USP 2 mg.
Brinzolamide is a carbonic anhydrase inhibitor which reduce intraocular pressure (IOP) by decreasing aqueous humor secretion in the ciliary processes of the eye. Brimonidine Tartrate is an alpha 2 adrenergic receptor agonist which reduces IOP by decreasing aqueous humor production and increasing uveoscleral outflow.
Azopres Br is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Instill one drop in the affected eye(s) three times daily.
Brinzolamide and Brimonidine Tartrate ophthalmic suspension is contraindicated in patients who are hypersensitive to any component of this product.
Shake well before use. For ophthalmic use only. Contact lenses should be removed during instillation of Brinzolamide and Brimonidine Tartrate ophthalmic suspension, but may be reinserted 15 minutes after instillation.
The most commonly reported side effects include blurred vision, eye irritation, bad taste and dry mouth.
Pregnancy: Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Brinzolamide and Brimonidine Tartrate ophthalmic suspension should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Lactation: It is not known whether Brinzolamide or Brimonidine Tartrate are excreted in human milk. Caution should be exercised while giving this ophthalmic suspension to a nursing mother.
No information available.
No information available.
Store below 30°C at cool and dry place, protect from light. Keep out of reach of children.
Azopres Br Eye Suspension : Each plastic dropper bottle contains 5 ml sterile Ophthalmic Suspension.